MYCOSIS FUNGOIDES/SEZARY SYNDROME
Clinical trials for MYCOSIS FUNGOIDES/SEZARY SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MYCOSIS FUNGOIDES/SEZARY SYNDROME trials appear
Sign up with your email to follow new studies for MYCOSIS FUNGOIDES/SEZARY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy tested for Tough-to-Treat skin cancer
Disease control OngoingThis study is testing whether combining two existing drugs, pembrolizumab and gemcitabine, can help control advanced forms of a rare skin cancer called mycosis fungoides or Sézary syndrome. It is for adults whose disease has worsened after at least one prior treatment. The main g…
Matched conditions: MYCOSIS FUNGOIDES/SEZARY SYNDROME
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug tested for Tough-to-Treat skin cancer
Disease control OngoingThis early-stage study is testing a new drug called tulmimetostat (DZR123) in patients with advanced mycosis fungoides or Sézary syndrome, which are types of skin lymphoma. The main goal is to check if the drug is safe and to find the right dose for future studies. Researchers wi…
Matched conditions: MYCOSIS FUNGOIDES/SEZARY SYNDROME
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC